Clinical Chemistry
Biomarkers of neurodegenerative disease
Clinical Chemistry
Biomarkers of neurodegenerative disease
9am – 9.30am BST, 23 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This presentation will cover
- The emergence of biomarkers of neurodegenerative disease
- Biomarkers of neurological damage
- Biomarkers in Multiple Sclerosis & Motor Neuron Disease
- Biomarkers in Alzheimer’s, Dementia and Parkinson's Disease
- Current & future relevance in diagnosis and prognosis of neurological disease
Speakers
Dr Amanda Heslegrave
Principal Research Fellow, UK DRI Fluid Biomarker Laboratory, University College London
Diabetic Ketoacidosis in type 2 diabetes – a consequence of treatment
Clinical Chemistry
Diabetic Ketoacidosis in type 2 diabetes – a consequence of treatment
9.30am – 10am BST, 23 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This talk will provide a brief overview of type 2 diabetes and current treatment strategies.
It will discuss the acute complication of Diabetic Ketoacidosis and how this can develop as a result of Sodium-Glucose Cotransporter 2 Inhibitors.
Speakers
![Sheri Scott CSci FIBMS SFHEA](https://congress.ibms.org/static/7c3a4647-8ed4-4a46-918c63a5ec474d03/eventfoliospeakerphoto2x_7a455221b20e4cf3de23b69510225e22_4a7c7e45a350/sheri-scott.jpg)
Sheri Scott CSci FIBMS SFHEA
Principal Lecturer in Biomedical Science and IBMS Council Member, Nottingham Trent University
Folate supplementation during pregnancy leading to gestational diabetes
Clinical Chemistry
Folate supplementation during pregnancy leading to gestational diabetes
10.30am – 11am BST, 23 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This presentation will discuss:
- Folate - a brief overview
- Folate status in pregnancy
- Adverse effects in pregnancy including links to diabetes mellitus.
Speakers
Dr Agata Sobczyńska- Malefora
Consultant Clinical Scientist, Synnovis, St Thomas’ Hospital
Investigating infertility and supporting assisted conception services
Clinical Chemistry
Investigating infertility and supporting assisted conception services
11am – 11.30am BST, 23 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will:
- Understand the interpretation and use of laboratory tests in the investigation of infertility and for assisted conception/IVF
- Gain knowledge on the patient perspective of assisted conception and IVF
- Understand how laboratory medicine supports embryology
Speakers
Dr Charlotte Hall
Consultant Embryologist, Laboratory Manager, Lister Fertility Clinic at The Portland Hospital, HCA Healthcare UK
Placental-like growth factor (PlGF) and soluble fmslike tyrosine kinase 1 (sFlt) testing for pre-eclampsia
Clinical Chemistry
Placental-like growth factor (PlGF) and soluble fmslike tyrosine kinase 1 (sFlt) testing for pre-eclampsia
11.30am – 12pm BST, 23 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will learn:
- What PlGF and sFlt are
- How they were identified
- How they can be used in relation to diagnosing pre-eclampsia
- Why it is important to identify pre-eclampsia
- How using PlGF and sFlt to diagnose pre-eclampsia compares to other current methods, and what this means for the patients
Speakers
![Professor Tim James](https://congress.ibms.org/static/ebca6416-cad1-417c-a8be398594541f53/eventfoliospeakerphoto2x_7a455221b20e4cf3de23b69510225e22_4a7c7e45a350/Tim-James.jpg)
Professor Tim James
Head Biomedical Scientist, Oxford University Hospitals NHS Foundation Trust
Capillary testing: Laboratory operational considerations
Clinical Chemistry
Capillary testing: Laboratory operational considerations
9am – 9.30am BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will be able to:
- Describe operational and logistical factors for laboratories utilising capillary blood samples
- Discuss UKAS considerations for laboratory testing of capillary blood samples
Speakers
Faecal Immunochemistry Testing (FIT)
Clinical Chemistry
Faecal Immunochemistry Testing (FIT)
9.30am – 10am BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This presentation will cover
- FIT testing in the context of Colorectal Cancer
- National screening pathway
- GP symptomatic referral pathway
- Methodology and equipment
- Standardisation and quality assurance
- Impact on colorectal cancer services
Speakers
Home sampling: Applications and challenges for the laboratory
Clinical Chemistry
Home sampling: Applications and challenges for the laboratory
10.30am – 11am BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This presentation will discuss:
- Improving access to healthcare
- Capillary blood sampling options for the laboratory
- Challenges and opportunities
Speakers
Professor Timothy McDonald
Clinical Director, Pathology Services, Royal Devon University Healthcare NHS Foundation Trust
Pregnancy in bariatric surgery patients and unique clinical Biochemistry considerations
Clinical Chemistry
Pregnancy in bariatric surgery patients and unique clinical Biochemistry considerations
11am – 11.30am BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
Gain an insight into the challenges faced by clinicians when caring for bariatric patients post surgery. Including dietary considerations to ensure that sufficient minerals and vitamins are available to mother and baby.
Speakers
Ovarian cancer: The SONATA study
Clinical Chemistry
Ovarian cancer: The SONATA study
11.30am – 12pm BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will:
- Understand current use of CA125 as recommended by NICE for the detection of Ovarian cancer.
- Understand the unmet needs the detection of Ovarian Cancer.
- Understand the findings of the SONATA study (NHS England funded) into the utility of ROMA (CA125 +HE4) as a potential new tool to detect ovarian cancer early.
Speakers
Professor Sudha Sundar
Professor of Gynaecological Cancer, Midland Metropolitan University Hospital
Meet the Specialist Advisory Panel: Clinical Chemistry
Clinical Chemistry
Meet the Specialist Advisory Panel: Clinical Chemistry
12.45pm – 1.45pm BST, 24 September 2025 ‐ 1 hour
Clinical Chemistry
This session allows the attendees to ask the clinical chemistry panel questions on a range of topics, such as IBMS qualifications, CPD, career advice etc.
Speakers
![Victoria Moyes](https://congress.ibms.org/static/fd7f554f-2b84-4e1e-8c6c6a33b5a08282/eventfoliospeakerphoto2x_7a455221b20e4cf3de23b69510225e22_4a7c7e45a350/Victoria-Moyse-image.jpg)
Martin McFadden
Diagnostic Programme Manager, South Tyneside and Sunderalnd NHS Foundation Trust
![Lee Peters MSc CSci FIBMS](https://congress.ibms.org/static/84dc92e0-8c15-48b5-9c021cf02be81cce/eventfoliospeakerphoto2x_7a455221b20e4cf3de23b69510225e22/Lee-Peters.jpg)
Lee Peters MSc CSci FIBMS
Blood Science Service Manager, Hywel Dda University Health Board
GP liaison: Pathology demand management
Clinical Chemistry
GP liaison: Pathology demand management
2pm – 2.30pm BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will understand how integrating disparate data sets can:
- Improve right-first-time diagnostics
- Reduce unwarranted variation
- Streamline processes to achieve faster and more reliable patient diagnoses.
Speakers
Higher Specialist Diploma case study: BRILS reagent shortage for free thyroxine
Clinical Chemistry
Higher Specialist Diploma case study: BRILS reagent shortage for free thyroxine
2.30pm – 3pm BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Speakers
Higher specialist diploma case study: Implementation of internal quality control monitoring spreadsheets
Clinical Chemistry
Higher specialist diploma case study: Implementation of internal quality control monitoring spreadsheets
3pm – 3.30pm BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
Through the discussion of his case study the presenter will:
- Describe how a new IQC monitoring solution was implemented
- Review success of implementation and lessons learned.
- Reflect on IQC monitoring in clinical laboratories
Speakers
The curious case of microplastics and their journey to the centre of the gut
Clinical Chemistry
The curious case of microplastics and their journey to the centre of the gut
4pm – 4.30pm BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This talk will provide a brief overview of microplastics and the current research into the topic. It will discuss the potential impact of microplastics on the gut and subsequent clinical biochemistry results.
Speakers
Clinical chemistry EQA report interpretation
Clinical Chemistry
Clinical chemistry EQA report interpretation
4.30pm – 5pm BST, 24 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
Speakers
![Gareth Davies](https://congress.ibms.org/static/49ec62b5-c579-4b9c-8794a2dab95b55bd/eventfoliospeakerphoto2x_7a455221b20e4cf3de23b69510225e22_4a7c7e45a350/Gareth-Davies-image.jpg)
Acute kidney injury and alerting
Clinical Chemistry
Acute kidney injury and alerting
9am – 9.30am BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This presentation will cover
- AKI background
- GIRFT and AKI survey
- National recommendations
Speakers
Dr Rachel Marrington
Consultant EQA Scientist & Deputy Director, Birmingham Quality (UK NEQAS)
Implementing the kidney function risk equation - a laboratory perspective
Clinical Chemistry
Implementing the kidney function risk equation - a laboratory perspective
9.30am – 10am BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Abstract
This presentation will cover
- What is the kidney function risk equation and how is it used?
- What are the main challenges in implementing the kidney function risk equation in your LIMS?
- What are the benefits of implementing the kidney function risk equation?
- Pilot outcomes and next steps.
Speakers
Susan Troup
Principal Clinical Scientist, South of Tyne & Wear Clinical Pathology Services
The dangers of nitrous oxide
Clinical Chemistry
The dangers of nitrous oxide
10.30am – 11am BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will:
- Learn basic biochemistry of how recreational Nitrous Oxide effects B12 and the consequent pathology that manifests as potentially irreversible nerve damage and muscle weakness.
- Learn how MMA and HCY are useful addition tests and how Total b12 and Active B12 are not helpful in these patients.
- Learn how patients present and can be treated.
Speakers
Nitrazene opiods and xylazine
Clinical Chemistry
Nitrazene opiods and xylazine
11am – 11.30am BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Speakers
Micronutrients and the acute phase response
Clinical Chemistry
Micronutrients and the acute phase response
11.30am – 12pm BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Speakers
Dr Barry Toole
Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Illicit medications – Welsh Emerging Drugs and identification of Novel Substances (WEDINOS)
Clinical Chemistry
Illicit medications – Welsh Emerging Drugs and identification of Novel Substances (WEDINOS)
2pm – 2.30pm BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will gain knowledge on:
- Illicit medications
- Internet drug purchases
- What is in them, and
- A guide to WEDINOS
Speakers
Ozempic and others (GLP-1 agonists)
Clinical Chemistry
Ozempic and others (GLP-1 agonists)
2.30pm – 3pm BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Speakers
Gliflozins and euglycaemic diabetic ketoacidosis
Clinical Chemistry
Gliflozins and euglycaemic diabetic ketoacidosis
3pm – 3.30pm BST, 25 September 2025 ‐ 30 mins
Clinical Chemistry
Learning outcomes
Delegates will understand:
- What are the glilozins
- mechanism of action
- clinical use
- Euglycaemic ketoacidosis (EDKA) and points to watch out for with patients suffering from EDKA
Speakers
Dr Nigel Brown
Consultant Clinical Biochemist, Northumbria Healthcare NHS Foundation Trust